Table 1.

Baseline characteristics of patients

CharacteristicOverall (n = 30)No evidence of CLS-B (n = 16)CLS-B showed (n = 14)P
Age, y
 Mean ± SD49.9 ± 10.448.6 ± 11.851.4 ± 8.70.46
 Median (range)50 (26–70)48.5 (26–70)51.5 (38–68)
Menopausal status, n (%)
 Pre16 (53)971.0
 Post14 (47)77
BMI
 Mean ± SD24.5 ± 4.731.6 ± 6.40.01
 Median (range)22.5 (19.3–35.7)29.2 (22.1–45.6)
BRCA status, n (%)
 Known mutation7 (23)521.0a
 No known mutation9 (30)63
 Unknown (not tested)14 (47)59
Breast surgery
 Ipsilateral breast cancer2 (7)110.68
 Contralateral breast cancer14 (47)86
 Carcinoma in situ12 (40)57
 No breast cancer history2 (7)20
  • aCompared among those with known BRCA status.